Anne Komé, PharmD, CPP, BCACP, CDCES, a clinical pharmacist practitioner in the Endocrinology Clinic at the UNC Chapel Hill ...
Diabetes disparities drive unequal CGM access and amputation risk, highlighting the need to address social, provider, and ...
Inhaled insulin (Afrezza; MannKind Corporation) continues to build a case for broader adoption in pediatric diabetes care.
The Medicare GLP-1 Bridge's July 1 launch is now the only concrete milestone on the calendar. Whether it becomes the ...
After FDA approval for children 6 and older, ADA data show inhaled insulin's safety and satisfaction benefits, but clinician ...
The approval of a new oral postexposure prophylaxis for COVID-19 marks a significant advancement in the disease's prevention ...
The moisturizer, sunscreen, or shampoo used in daily routines may contain dozens of plastic-associated chemicals linked to ...
Men and urban minority patients with early-onset CRC face elevated CVD death risk, highlighting gaps in survivorship care and ...
Mixed κ agonism and μ antagonism/partial agonism raises mechanistic and abuse-liability questions, with nausea, vomiting, ...
Ajai Chari, MD, unpacks resistance mechanisms, treatment sequencing, and why myeloma’s future may be brighter than anyone ...
SEER-Medicare data (n=54,344; mean age 77.7 years) showed significant unadjusted Black-White gaps in localized diagnosis, ...
Real-world data suggest nirogacestat boosts response in desmoid tumor vs standard-of-care treatment, but small cohorts leave ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results